Slashdot.org

Syndicate content Slashdot
News for nerds, stuff that matters
Updated: 1 hour 30 min ago

Canada Will Ship 800 Doses of Experimental Ebola Drug to WHO

Sun, 10/19/2014 - 01:15
The WSJ reports that 800 doses of an experimental vaccine for Ebola, developed over a decade at Public Health Agency of Canada’s main laboratory in Winnipeg, will be shipped to the World Health Organization in an effort to help fight the ongoing Ebola crisis in West Africa: The vaccine will be shipped by air from Winnipeg, Manitoba, to the University Hospital of Geneva via specialized courier. The vials will be sent in three separate shipments as a precautionary measure, due to the challenges in moving a vaccine that must kept at a very low temperature at all times. ... The vaccine had shown “very promising results in animal research” and earlier this week, Ottawa announced the start of clinical trials on humans at the Walter Reed Army Institute of Research in the U.S. ... The government has licensed NewLink Genetics Corp. , of the U.S., through its wholly owned subsidiary BioProtection Systems Corp. to further develop the vaccine for use in humans. The government owns the intellectual property rights associated with the vaccine.

Read more of this story at Slashdot.








Canada Will Ship 800 Doses of Experimental Ebola Drug to WHO

Sun, 10/19/2014 - 01:15
The WSJ reports that 800 doses of an experimental vaccine for Ebola, developed over a decade at Public Health Agency of Canada’s main laboratory in Winnipeg, will be shipped to the World Health Organization in an effort to help fight the ongoing Ebola crisis in West Africa: The vaccine will be shipped by air from Winnipeg, Manitoba, to the University Hospital of Geneva via specialized courier. The vials will be sent in three separate shipments as a precautionary measure, due to the challenges in moving a vaccine that must kept at a very low temperature at all times. ... The vaccine had shown “very promising results in animal research” and earlier this week, Ottawa announced the start of clinical trials on humans at the Walter Reed Army Institute of Research in the U.S. ... The government has licensed NewLink Genetics Corp. , of the U.S., through its wholly owned subsidiary BioProtection Systems Corp. to further develop the vaccine for use in humans. The government owns the intellectual property rights associated with the vaccine.

Read more of this story at Slashdot.








Canada Will Ship 800 Doses of Experimental Ebola Drug to WHO

Sun, 10/19/2014 - 01:15
The WSJ reports that 800 doses of an experimental vaccine for Ebola, developed over a decade at Public Health Agency of Canada’s main laboratory in Winnipeg, will be shipped to the World Health Organization in an effort to help fight the ongoing Ebola crisis in West Africa: The vaccine will be shipped by air from Winnipeg, Manitoba, to the University Hospital of Geneva via specialized courier. The vials will be sent in three separate shipments as a precautionary measure, due to the challenges in moving a vaccine that must kept at a very low temperature at all times. ... The vaccine had shown “very promising results in animal research” and earlier this week, Ottawa announced the start of clinical trials on humans at the Walter Reed Army Institute of Research in the U.S. ... The government has licensed NewLink Genetics Corp. , of the U.S., through its wholly owned subsidiary BioProtection Systems Corp. to further develop the vaccine for use in humans. The government owns the intellectual property rights associated with the vaccine.

Read more of this story at Slashdot.








Canada Will Ship 800 Doses of Experimental Ebola Drug to WHO

Sun, 10/19/2014 - 01:15
The WSJ reports that 800 doses of an experimental vaccine for Ebola, developed over a decade at Public Health Agency of Canada’s main laboratory in Winnipeg, will be shipped to the World Health Organization in an effort to help fight the ongoing Ebola crisis in West Africa: The vaccine will be shipped by air from Winnipeg, Manitoba, to the University Hospital of Geneva via specialized courier. The vials will be sent in three separate shipments as a precautionary measure, due to the challenges in moving a vaccine that must kept at a very low temperature at all times. ... The vaccine had shown “very promising results in animal research” and earlier this week, Ottawa announced the start of clinical trials on humans at the Walter Reed Army Institute of Research in the U.S. ... The government has licensed NewLink Genetics Corp. , of the U.S., through its wholly owned subsidiary BioProtection Systems Corp. to further develop the vaccine for use in humans. The government owns the intellectual property rights associated with the vaccine.

Read more of this story at Slashdot.








Canada Will Ship 800 Doses of Experimental Ebola Drug to WHO

Sun, 10/19/2014 - 01:15
The WSJ reports that 800 doses of an experimental vaccine for Ebola, developed over a decade at Public Health Agency of Canada’s main laboratory in Winnipeg, will be shipped to the World Health Organization in an effort to help fight the ongoing Ebola crisis in West Africa: The vaccine will be shipped by air from Winnipeg, Manitoba, to the University Hospital of Geneva via specialized courier. The vials will be sent in three separate shipments as a precautionary measure, due to the challenges in moving a vaccine that must kept at a very low temperature at all times. ... The vaccine had shown “very promising results in animal research” and earlier this week, Ottawa announced the start of clinical trials on humans at the Walter Reed Army Institute of Research in the U.S. ... The government has licensed NewLink Genetics Corp. , of the U.S., through its wholly owned subsidiary BioProtection Systems Corp. to further develop the vaccine for use in humans. The government owns the intellectual property rights associated with the vaccine.

Read more of this story at Slashdot.








Canada Will Ship 800 Doses of Experimental Ebola Drug to WHO

Sun, 10/19/2014 - 01:15
The WSJ reports that 800 doses of an experimental vaccine for Ebola, developed over a decade at Public Health Agency of Canada’s main laboratory in Winnipeg, will be shipped to the World Health Organization in an effort to help fight the ongoing Ebola crisis in West Africa: The vaccine will be shipped by air from Winnipeg, Manitoba, to the University Hospital of Geneva via specialized courier. The vials will be sent in three separate shipments as a precautionary measure, due to the challenges in moving a vaccine that must kept at a very low temperature at all times. ... The vaccine had shown “very promising results in animal research” and earlier this week, Ottawa announced the start of clinical trials on humans at the Walter Reed Army Institute of Research in the U.S. ... The government has licensed NewLink Genetics Corp. , of the U.S., through its wholly owned subsidiary BioProtection Systems Corp. to further develop the vaccine for use in humans. The government owns the intellectual property rights associated with the vaccine.

Read more of this story at Slashdot.








Canada Will Ship 800 Doses of Experimental Ebola Drug to WHO

Sun, 10/19/2014 - 01:15
The WSJ reports that 800 doses of an experimental vaccine for Ebola, developed over a decade at Public Health Agency of Canada’s main laboratory in Winnipeg, will be shipped to the World Health Organization in an effort to help fight the ongoing Ebola crisis in West Africa: The vaccine will be shipped by air from Winnipeg, Manitoba, to the University Hospital of Geneva via specialized courier. The vials will be sent in three separate shipments as a precautionary measure, due to the challenges in moving a vaccine that must kept at a very low temperature at all times. ... The vaccine had shown “very promising results in animal research” and earlier this week, Ottawa announced the start of clinical trials on humans at the Walter Reed Army Institute of Research in the U.S. ... The government has licensed NewLink Genetics Corp. , of the U.S., through its wholly owned subsidiary BioProtection Systems Corp. to further develop the vaccine for use in humans. The government owns the intellectual property rights associated with the vaccine.

Read more of this story at Slashdot.








Canada Will Ship 800 Doses of Experimental Ebola Drug to WHO

Sun, 10/19/2014 - 01:15
The WSJ reports that 800 doses of an experimental vaccine for Ebola, developed over a decade at Public Health Agency of Canada’s main laboratory in Winnipeg, will be shipped to the World Health Organization in an effort to help fight the ongoing Ebola crisis in West Africa: The vaccine will be shipped by air from Winnipeg, Manitoba, to the University Hospital of Geneva via specialized courier. The vials will be sent in three separate shipments as a precautionary measure, due to the challenges in moving a vaccine that must kept at a very low temperature at all times. ... The vaccine had shown “very promising results in animal research” and earlier this week, Ottawa announced the start of clinical trials on humans at the Walter Reed Army Institute of Research in the U.S. ... The government has licensed NewLink Genetics Corp. , of the U.S., through its wholly owned subsidiary BioProtection Systems Corp. to further develop the vaccine for use in humans. The government owns the intellectual property rights associated with the vaccine.

Read more of this story at Slashdot.








Despite Patent Settlement, Apple Pulls Bose Merchandise From Its Stores

Sat, 10/18/2014 - 22:13
Apple has long sold Bose headphones and speakers in its retail stores, including in the time since it acquired Bose-competitor Beats Audio, and despite the lawsuit filed by Bose against Apple alleging patent violations on the part of Beats. That's come to an end this week, though: Apple's dropped Bose merchandise both in its retail locations and online, despite recent news that the two companies have settled the patent suit.

Read more of this story at Slashdot.








Despite Patent Settlement, Apple Pulls Bose Merchandise From Its Stores

Sat, 10/18/2014 - 22:13
Apple has long sold Bose headphones and speakers in its retail stores, including in the time since it acquired Bose-competitor Beats Audio, and despite the lawsuit filed by Bose against Apple alleging patent violations on the part of Beats. That's come to an end this week, though: Apple's dropped Bose merchandise both in its retail locations and online, despite recent news that the two companies have settled the patent suit.

Read more of this story at Slashdot.








Despite Patent Settlement, Apple Pulls Bose Merchandise From Its Stores

Sat, 10/18/2014 - 22:13
Apple has long sold Bose headphones and speakers in its retail stores, including in the time since it acquired Bose-competitor Beats Audio, and despite the lawsuit filed by Bose against Apple alleging patent violations on the part of Beats. That's come to an end this week, though: Apple's dropped Bose merchandise both in its retail locations and online, despite recent news that the two companies have settled the patent suit.

Read more of this story at Slashdot.








Despite Patent Settlement, Apple Pulls Bose Merchandise From Its Stores

Sat, 10/18/2014 - 22:13
Apple has long sold Bose headphones and speakers in its retail stores, including in the time since it acquired Bose-competitor Beats Audio, and despite the lawsuit filed by Bose against Apple alleging patent violations on the part of Beats. That's come to an end this week, though: Apple's dropped Bose merchandise both in its retail locations and online, despite recent news that the two companies have settled the patent suit.

Read more of this story at Slashdot.








Despite Patent Settlement, Apple Pulls Bose Merchandise From Its Stores

Sat, 10/18/2014 - 22:13
Apple has long sold Bose headphones and speakers in its retail stores, including in the time since it acquired Bose-competitor Beats Audio, and despite the lawsuit filed by Bose against Apple alleging patent violations on the part of Beats. That's come to an end this week, though: Apple's dropped Bose merchandise both in its retail locations and online, despite recent news that the two companies have settled the patent suit.

Read more of this story at Slashdot.








Despite Patent Settlement, Apple Pulls Bose Merchandise From Its Stores

Sat, 10/18/2014 - 22:13
Apple has long sold Bose headphones and speakers in its retail stores, including in the time since it acquired Bose-competitor Beats Audio, and despite the lawsuit filed by Bose against Apple alleging patent violations on the part of Beats. That's come to an end this week, though: Apple's dropped Bose merchandise both in its retail locations and online, despite recent news that the two companies have settled the patent suit.

Read more of this story at Slashdot.








Despite Patent Settlement, Apple Pulls Bose Merchandise From Its Stores

Sat, 10/18/2014 - 22:13
Apple has long sold Bose headphones and speakers in its retail stores, including in the time since it acquired Bose-competitor Beats Audio, and despite the lawsuit filed by Bose against Apple alleging patent violations on the part of Beats. That's come to an end this week, though: Apple's dropped Bose merchandise both in its retail locations and online, despite recent news that the two companies have settled the patent suit.

Read more of this story at Slashdot.








Despite Patent Settlement, Apple Pulls Bose Merchandise From Its Stores

Sat, 10/18/2014 - 22:13
Apple has long sold Bose headphones and speakers in its retail stores, including in the time since it acquired Bose-competitor Beats Audio, and despite the lawsuit filed by Bose against Apple alleging patent violations on the part of Beats. That's come to an end this week, though: Apple's dropped Bose merchandise both in its retail locations and online, despite recent news that the two companies have settled the patent suit.

Read more of this story at Slashdot.








Despite Patent Settlement, Apple Pulls Bose Merchandise From Its Stores

Sat, 10/18/2014 - 22:13
Apple has long sold Bose headphones and speakers in its retail stores, including in the time since it acquired Bose-competitor Beats Audio, and despite the lawsuit filed by Bose against Apple alleging patent violations on the part of Beats. That's come to an end this week, though: Apple's dropped Bose merchandise both in its retail locations and online, despite recent news that the two companies have settled the patent suit.

Read more of this story at Slashdot.








Despite Patent Settlement, Apple Pulls Bose Merchandise From Its Stores

Sat, 10/18/2014 - 22:13
Apple has long sold Bose headphones and speakers in its retail stores, including in the time since it acquired Bose-competitor Beats Audio, and despite the lawsuit filed by Bose against Apple alleging patent violations on the part of Beats. That's come to an end this week, though: Apple's dropped Bose merchandise both in its retail locations and online, despite recent news that the two companies have settled the patent suit.

Read more of this story at Slashdot.








Despite Patent Settlement, Apple Pulls Bose Merchandise From Its Stores

Sat, 10/18/2014 - 22:13
Apple has long sold Bose headphones and speakers in its retail stores, including in the time since it acquired Bose-competitor Beats Audio, and despite the lawsuit filed by Bose against Apple alleging patent violations on the part of Beats. That's come to an end this week, though: Apple's dropped Bose merchandise both in its retail locations and online, despite recent news that the two companies have settled the patent suit.

Read more of this story at Slashdot.








Despite Patent Settlement, Apple Pulls Bose Merchandise From Its Stores

Sat, 10/18/2014 - 22:13
Apple has long sold Bose headphones and speakers in its retail stores, including in the time since it acquired Bose-competitor Beats Audio, and despite the lawsuit filed by Bose against Apple alleging patent violations on the part of Beats. That's come to an end this week, though: Apple's dropped Bose merchandise both in its retail locations and online, despite recent news that the two companies have settled the patent suit.

Read more of this story at Slashdot.








Comment